key: cord-0771244-0i1iol98 authors: Le Guennec, Loïc; Devianne, Julia; Jalin, Laurence; Cao, Albert; Galanaud, Damien; Navarro, Vincent; Boutolleau, David; Rohaut, Benjamin; Weiss, Nicolas; Demeret, Sophie title: Orbitofrontal involvement in a neuroCOVID‐19 patient date: 2020-06-26 journal: Epilepsia DOI: 10.1111/epi.16612 sha: 7be9e6d67314e85dd12f9e76fd3e3de9b4ed0cd0 doc_id: 771244 cord_uid: 0i1iol98 Neurological manifestations of COVID‐19 such as encephalitis and seizures have been increasingly reported, but our understanding of COVID‐related brain injury is still limited. Herein we describe prefrontal involvement in a COVID‐19 patient who presented prior anosmia, raising the question of a potential trans‐olfactory‐bulb brain invasion. Several COVID-19-related cerebral manifestations have been reported since the start of the pandemic 1-6 . The pathophysiological mechanisms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) brain injury are still unknown and debated, with the exception of cerebrovascular complications, probably related to a hypercoagulable state, as shown by the high rate of thrombotic events in COVID-19 patients [6] [7] [8] [9] . Many authors have suggested that the virus enters the central nervous system (CNS) through olfactory neurons 10 , as SARS-CoV-1 invades the brains of mice brain in experimental models 11 . This mode of entry could This article is protected by copyright. All rights reserved also explain the frequency of anosmia observed during onset of COVID-19 infection 1 . However, after several months of a worldwide COVID-19 pandemic, there is no substantial evidence for the presence of SARS-Cov-2 in the brain, with the exception of two patients with CSF that tested positive for COVID-19 3, 12 . If we assume that SARS-CoV-2 invades the brain through the olfactory pathway, the orbital prefrontal cortex, adjacent to the olfactory bulb, should be the first region of the brain affected . This hypothesis is supported by brain 18fluoro-2-deoxy-d-glucose (18FDG) positron emission tomography computed tomography (PET-CT) that showed hypometabolism within the orbitofrontal cortex in a COVID-19 patient with isolated anosmia 13 . In addition, another recent study found that 88.9% of electroencephalograms (EEGs) performed in COVID-19 patients for suspected encephalopathy and/or seizure-like events revealed epileptiform discharges, mostly within frontal lobes 14 . Herein we report a case of status epilepticus as the first manifestation of COVID-19. Right frontal lobe involvement was demonstrated by both MRI and EEG. A 69-year-old man was admitted to ICU for status epilepticus requiring endotracheal intubation, preceded by a 5-day history of cough, fever, and anosmia. SARS-CoV-2 was detected by Reverse transcription-polymerase chain-reaction (RT-PCR) in a tracheal aspirate.. Medical history was significant for diabetes mellitus, hypertension, and a single seizure, which had occurred one year earlier, related to hyperglycaemia and uncontrolled diabetes. Upon admission to our ICU, the patient was treated with intravenous levetiracetam. Brain CT (computerized tomography) was unremarkable, and This article is protected by copyright. All rights reserved electroencephalography (EEG) showed repetitive 1 Hz rhythmic bursts over the right frontal region, suggestive of a non-convulsive status epilepticus (Fig 1) . Cerebrospinal fluid (CSF) examination was unremarkable, showing 1 leukocyte per cubic millimeter, 18 red blood cells per cubic millimeter, and protein and glucose levels respectively at 0.66 g/L and 10.5mmol/L (blood glucose at 20mmol/L). RT-PCR assay of the CSF was negative for SARS-CoV-2. All other tests for infectious agents and autoimmune disease were negative in serum and CSF (table S1). Brain MRI revealed hyperintensity of the right orbital prefrontal cortex adjacent to the olfactory bulb, which seemed to spread towards the right mesial prefrontal cortex and to the right caudate nucleus (Figure 2 , A, B, C and D). No gadolinium enhancement was observed. After a multidisciplinary discussion, a treatment with IV-Immunoglobulins at 2g/kg was administered. EEG showed persistent short-interval (0.7-1.2 sec) lateralized periodic discharges (LPDs) over the right frontal lobe on day 2. The patient improved after one week, allowing for weaning from mechanical ventilation, but he presented signs of frontal lobe syndrome including verbal perseverations and imitation behavior, and was drowsy for several days after extubation. MRI performed at day 15 showed the persistence of a marked hyperintensity of the right caudate nucleus and a significant decrease of the hyperintensity of the prefrontal cortex ( Figure 2 , E, F, G, and H). MRI performed at day 30 was normal. We concluded that initial MRI hyperintensities were partly due to peri-ictal diffusion abnormalities. We hypothesize that this particular form of orbitofrontal status epilepticus may have been triggered by the passage of SARS-CoV2 through the olfactory pathway. This article is protected by copyright. All rights reserved This case of orbital and mesial prefrontal involvement of COVID-19 provides insight into the early steps of SARS-CoV-2 brain invasion, and reinforces the broadly suspected hypothesis of neuroinvasive directly through olfactory epithelium, but many questions still remain unanswered.. Firstly, if we assume that electrophysiological and radiological abnormalities result from direct viral injury to neurons, the expected consequences would be neuronal death and necrosis, classically reported in acute necrotizing encephalitis related to Herpes Simplex Virus-1. In this case, the virus would invade the CNS through retrograde axonal transport after olfactory bulb invasion, and then spread toward cortical and/or deep gray matter structures. In our patient, clinical and radiological features improved making direct viral damage unlikely. Moreover, CSF was negative for SARS-CoV-2. However, since no brain biopsy was performed due to the patient's clinical improvement, we cannot exclude that this process occurred. Secondly, post-infectious encephalitis could be hypothesized. The radiological pattern observed in our case was strictly different from that observed in acute disseminated encephalomyelitis 15, 16 , but immune-mediated encephalitis cannot be ruled out, even if an extensive work-up was inconclusive. In addition, the patient received IV-Immunoglobulins, with clinical and radiological recovery, but evidence for a causal relationship between treatment and improvement is weak, and there is little of evidence for efficacy of IV-Immunoglobulins in COVID-19. Thirdly, another possibility is sepsis-associated encephalopathy, due to blood brain barrier (BBB) dysfunction related to systemic infection 17 . Viral infection of olfactory epithelium, This article is protected by copyright. All rights reserved could lead to release of regional cytokines, which, in turn, could cause involvement of the contiguous orbitofrontal cortex, through local BBB leakage, with migration of leukocytes and activation of microglial cells. Finally, this patient with significant vascular risk factors could have had previous unknown right frontal vascular disease that produced seizures in the setting of an intercurrent infection, but normal brain MRI at day 30 excluded this hypothesis. To conclude, whether COVID-19-related central nervous system dysfunction results from direct viral injury, indirect consequences of immune-mediated disease, systemic effects of infection, or local effects of the virus is still a matter of debate and these hypotheses are not mutually exclusive.T However, the recent reports of frontal hypometabolism on PET-CT, frontal EEG abnormalities during COVID-19, and our case description are strong arguments in favor of a "SARS-CoV2 related-frontal involvement" whether direct or indirect. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Neurologic Features in Severe SARS-CoV-2 Infection N A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features Radiology Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy Cureus Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young N COVID-19 and its implications for thrombosis and anticoagulation Blood ST-Segment Elevation in Patients with Covid-19 -A Case Series Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study Multiple organ infection and the pathogenesis of SARS Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2 Sars-Cov-2: Underestimated damage to nervous system Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19 Acad Radiol EEG findings in acutely ill patients investigated for SARS-CoV2/COVID-19: a small case series preliminary report Epilepsia Open Consensus definitions proposed for pediatric multiple sclerosis and related disorders Neurology Acute disseminated encephalomyelitisin the intensive care unit:clinical features and outcome of 20 adults Intensive Care Med This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved The authors thank Pr Hervé Vespignani and Pr Louis Maillard from Serenity Medical Services (Bioserenity), who performed the first EEG. The authors thank the iCRIN program from "Investissements d'avenir" ANR-10-IAIHU-06, and the Fondation de l'APHP pour la Recherche. The authors thank Dr Alaina Borden for her assistance during the preparation of the manuscript. In accordance with the ethical standards of our hospital's Institutional Review Board (Committee for the Protection of Human Subjects) and current French law, informed consent for demographic, physiological and hospital-outcome data analyses was not obtained because this case report did not modify existing diagnostic or therapeutic strategies. Nonetheless, patients and/or relatives were informed about the anonymous data collection and told that they could decline inclusion. This database is registered at the Commission Nationale de l'Informatique et des Libertés (CNIL, registration no. 1950673).